SARS-CoV-2 seroconversion in children attending daycare versus adults in Germany between October 2020 and June 2021

Ulrike Kubisch1, Anna Sandoni2, Juliane Wurm2

  • 1Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany. kubischu@rki.de.

Communications Medicine
|September 15, 2023
PubMed

Insights

Young children show higher SARS-CoV-2 seroconversion rates than adults. High viral load and delayed antibody testing correlate with seroconversion, suggesting antibody development in children post-infection.

Area of Science:

  • Pediatric infectious diseases
  • Immunology
  • Epidemiology

Background:

  • Limited data exists on SARS-CoV-2 seroconversion rates in children under six.
  • This study addresses the scarcity of information by comparing seroconversion in young children and adults.

Purpose of the Study:

  • To compare SARS-CoV-2 seroconversion rates between young children and adults.
  • To identify factors associated with seroconversion in SARS-CoV-2 infected individuals.

Main Methods:

  • The COALA study analyzed SARS-CoV-2 transmission in daycare centers and households.
  • PCR-positive individuals (n=91, including 38 children aged 1-6) had IgG-antibodies tested from two blood samples collected within five weeks.

Main Results:

  • Seroconversion rates were significantly higher in young children (97.4%) compared to adults (66%).
  • Higher viral load and a longer interval between infection and antibody testing were associated with seroconversion.

Conclusions:

  • Young children exhibit substantial specific antibody development following SARS-CoV-2 infection.
  • This antibody response may offer temporary protection against reinfection or severe disease in this age group.
Abstract

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
621
Vaccinations01:51

Vaccinations

Overview
44.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K